Zyla Life Sciences — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3bb28642-0a78-4dd9-a58c-7a6d06a08259/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2019 | $-35.6M | 2019-02-01 – 2019-12-31 | evidence 0001558370-20-003190 |
| FY 2018 | $-57.6M | 2018-01-01 – 2018-12-31 | evidence 0001558370-19-002647 |
| FY 2017 | $-68.2M | 2017-01-01 – 2017-12-31 | evidence 0001558370-18-002180 |
| FY 2016 | $-81.0M | 2016-01-01 – 2016-12-31 | evidence 0001558370-17-001692 |
| FY 2015 | $-52.2M | 2015-01-01 – 2015-12-31 | evidence 0001558370-16-004071 |
| FY 2014 | $-37.1M | 2014-01-01 – 2014-12-31 | evidence 0001047469-15-002296 |
| FY 2013 | $-11.4M | 2013-01-01 – 2013-12-31 | evidence 0001047469-15-002296 |
| FY 2012 | $-5.3M | 2012-01-01 – 2012-12-31 | evidence 0001047469-15-002296 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).